TCN2
Transcobalamin-2
Also known as: D22S676, D22S750, TC2, TCO2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20062
- Gene
- TCN2
- Ensembl
- ENSG00000185339
- Chromosome
- 22
- Canonical length
- 427 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the vitamin B12-binding protein family. This family of proteins, alternatively referred to as R binders, is expressed in various tissues and secretions. This plasma protein binds cobalamin and mediates the transport of cobalamin into cells. This protein and other mammalian cobalamin-binding proteins, such as transcobalamin I and gastric intrisic factor, may have evolved by duplication of a common ancestral gene. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
427 residues, UniProt reviewed canonical sequence.
>P20062|TCN2
1 MRHLGAFLFL LGVLGALTEM CEIPEMDSHL VEKLGQHLLP WMDRLSLEHL NPSIYVGLRL
61 SSLQAGTKED LYLHSLKLGY QQCLLGSAFS EDDGDCQGKP SMGQLALYLL ALRANCEFVR
121 GHKGDRLVSQ LKWFLEDEKR AIGHDHKGHP HTSYYQYGLG ILALCLHQKR VHDSVVDKLL
181 YAVEPFHQGH HSVDTAAMAG LAFTCLKRSN FNPGRRQRIT MAIRTVREEI LKAQTPEGHF
241 GNVYSTPLAL QFLMTSPMRG AELGTACLKA RVALLASLQD GAFQNALMIS QLLPVLNHKT
301 YIDLIFPDCL APRVMLEPAA ETIPQTQEII SVTLQVLSLL PPYRQSISVL AGSTVEDVLK
361 KAHELGGFTY ETQASLSGPY LTSVMGKAAG EREFWQLLRD PNTPLLQGIA DYRPKDGETI
421 ELRLVSWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 108 nTPM
Expression across tissuesHPA
Tissue
- kidney: 108 nTPM
- small intestine: 56 nTPM
- gallbladder: 47 nTPM
- adipose tissue: 46 nTPM
- spleen: 44 nTPM
- seminal vesicle: 42 nTPM
Single-cell type
- enterocytes: 531 nCPM
- kupffer cells: 221 nCPM
- monocytes: 85 nCPM
- macrophages: 67 nCPM
- vascular endothelial cells: 66 nCPM
- hofbauer cells: 64 nCPM
Immune cell
- intermediate monocyte: 66 nTPM
- classical monocyte: 43 nTPM
- non-classical monocyte: 24 nTPM
- total PBMC: 19 nTPM
- myeloid DC: 7.6 nTPM
- plasmacytoid DC: 1.5 nTPM
Brain region
- thalamus: 26 nTPM
- pons: 22 nTPM
- medulla oblongata: 21 nTPM
- choroid plexus: 20 nTPM
- cerebellum: 18 nTPM
- hypothalamus: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TCN2.
Disease | AllUniProt
Conditions TCN2 is implicated in, by any mechanism.
- Transcobalamin II deficiency (TCN2D) MIM:275350
Disease | GeneticClinVar
70 pathogenic / likely-pathogenic of 797 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Transcobalamin II deficiency
- TCN2-related disorder
- Inborn genetic diseases
- Pancytopenia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.12
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TCN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCN2 as an antibody target. Whether an autoantibody or antibody against TCN2 could matter depends on whether native TCN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCN2 is annotated as secreted, so native TCN2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TCN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...